Discovery of the Impact of Targeted Lung Denervation (TLD) on the Severe and Very Severe COPD Population
NCT03213080 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-02-18
Summary
The DISCOVER TLD study is a multicenter, prospective, single-arm study designed to record the clinical outcomes of the CE-marked Nuvaira™ Lung Denervation System, in a subset of its CE-marked approved indication. This study is being conducted in Europe.
Conditions
Interventions
- DEVICE
-
Targeted Lung Denervation (TLD)
Targeted Lung Denervation (TLD) procedure.
Sponsors & Collaborators
-
Nuvaira, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-31
- Primary Completion
- 2021-09-30
- Completion
- 2021-09-30
More Related Trials
-
Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness
NCT03137992 ·Status: COMPLETED ·Phase: PHASE3
-
US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
NCT00515164 ·Status: COMPLETED ·Phase: PHASE2
-
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
NCT00784550 ·Status: COMPLETED ·Phase: PHASE4
-
NAL ER IPF Respiratory Function and Safety Study
NCT07036029 ·Status: RECRUITING ·Phase: PHASE1
-
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT02518139 ·Status: COMPLETED ·Phase: PHASE3
-
TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis
NCT04589260 ·Status: TERMINATED ·Phase: PHASE1
-
Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema
NCT00716053 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects
NCT05817240 ·Status: COMPLETED ·Phase: PHASE1
-
Tiotropium in Patients With Tuberculosis (TB) Destroyed Lung
NCT01365702 ·Status: UNKNOWN
-
TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients With COPD
NCT04671355 ·Status: WITHDRAWN ·Phase: PHASE4
-
Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD
NCT06841640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI
NCT02018549 ·Status: COMPLETED ·Phase: PHASE2
-
JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF
NCT03538301 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
NCT01597635 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers
NCT01661244 ·Status: COMPLETED ·Phase: PHASE1
-
Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
NCT05671835 ·Status: COMPLETED ·Phase: PHASE2
-
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
NCT00347659 ·Status: COMPLETED ·Phase: PHASE1
-
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
NCT01320566 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Outcomes of Once-Daily ICS/LABA/LAMA + PRN Respiratory Therapy Treatments in Hospitalized Patients With COPD Exacerbations
NCT05292053 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NCT07119229 ·Status: RECRUITING ·Phase: NA
-
Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172482 ·Status: COMPLETED
-
Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172391 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema
NCT05949645 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).
NCT00239408 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
NCT05897424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2